nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Body temperature increased—Dactinomycin—muscle cancer	0.00197	0.00197	CcSEcCtD
Valganciclovir—Decreased appetite—Vincristine—muscle cancer	0.00194	0.00194	CcSEcCtD
Valganciclovir—Cough—Etoposide—muscle cancer	0.00193	0.00193	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Vincristine—muscle cancer	0.00192	0.00192	CcSEcCtD
Valganciclovir—Fatigue—Vincristine—muscle cancer	0.00192	0.00192	CcSEcCtD
Valganciclovir—Convulsion—Etoposide—muscle cancer	0.00192	0.00192	CcSEcCtD
Valganciclovir—Hypertension—Etoposide—muscle cancer	0.00191	0.00191	CcSEcCtD
Valganciclovir—Pain—Vincristine—muscle cancer	0.0019	0.0019	CcSEcCtD
Valganciclovir—Constipation—Vincristine—muscle cancer	0.0019	0.0019	CcSEcCtD
Valganciclovir—Pain in extremity—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Valganciclovir—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Valganciclovir—Eosinophilia—Methotrexate—muscle cancer	0.00188	0.00188	CcSEcCtD
Valganciclovir—Migraine—Doxorubicin—muscle cancer	0.00187	0.00187	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00187	0.00187	CcSEcCtD
Valganciclovir—Pancreatitis—Methotrexate—muscle cancer	0.00186	0.00186	CcSEcCtD
Valganciclovir—Discomfort—Etoposide—muscle cancer	0.00186	0.00186	CcSEcCtD
Valganciclovir—Hypersensitivity—Dactinomycin—muscle cancer	0.00184	0.00184	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Vincristine—muscle cancer	0.00182	0.00182	CcSEcCtD
Valganciclovir—Confusional state—Etoposide—muscle cancer	0.00182	0.00182	CcSEcCtD
Valganciclovir—Pancytopenia—Methotrexate—muscle cancer	0.0018	0.0018	CcSEcCtD
Valganciclovir—Anaphylactic shock—Etoposide—muscle cancer	0.0018	0.0018	CcSEcCtD
Valganciclovir—Infection—Etoposide—muscle cancer	0.00179	0.00179	CcSEcCtD
Valganciclovir—Ataxia—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Valganciclovir—Asthenia—Dactinomycin—muscle cancer	0.00179	0.00179	CcSEcCtD
Valganciclovir—Blood creatinine increased—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Valganciclovir—Neutropenia—Methotrexate—muscle cancer	0.00178	0.00178	CcSEcCtD
Valganciclovir—Dysuria—Methotrexate—muscle cancer	0.00178	0.00178	CcSEcCtD
Valganciclovir—Dehydration—Doxorubicin—muscle cancer	0.00177	0.00177	CcSEcCtD
Valganciclovir—Thrombocytopenia—Etoposide—muscle cancer	0.00177	0.00177	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00177	0.00177	CcSEcCtD
Valganciclovir—Tachycardia—Etoposide—muscle cancer	0.00176	0.00176	CcSEcCtD
Valganciclovir—Abdominal pain—Vincristine—muscle cancer	0.00176	0.00176	CcSEcCtD
Valganciclovir—Body temperature increased—Vincristine—muscle cancer	0.00176	0.00176	CcSEcCtD
Valganciclovir—Skin disorder—Etoposide—muscle cancer	0.00175	0.00175	CcSEcCtD
Valganciclovir—Erectile dysfunction—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Valganciclovir—Dry skin—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Valganciclovir—Hyperhidrosis—Etoposide—muscle cancer	0.00174	0.00174	CcSEcCtD
Valganciclovir—Abdominal pain upper—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Methotrexate—muscle cancer	0.00173	0.00173	CcSEcCtD
Valganciclovir—Hypokalaemia—Doxorubicin—muscle cancer	0.00173	0.00173	CcSEcCtD
Valganciclovir—Anorexia—Etoposide—muscle cancer	0.00172	0.00172	CcSEcCtD
Valganciclovir—Diarrhoea—Dactinomycin—muscle cancer	0.00171	0.00171	CcSEcCtD
Valganciclovir—Pneumonia—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Valganciclovir—Nasopharyngitis—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Valganciclovir—Infestation NOS—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Valganciclovir—Infestation—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Valganciclovir—Depression—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Valganciclovir—Hypotension—Etoposide—muscle cancer	0.00169	0.00169	CcSEcCtD
Valganciclovir—Gastritis—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Valganciclovir—Renal failure—Methotrexate—muscle cancer	0.00167	0.00167	CcSEcCtD
Valganciclovir—Abdominal distension—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Valganciclovir—Stomatitis—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Valganciclovir—Influenza—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Valganciclovir—Dysphagia—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Valganciclovir—Hypersensitivity—Vincristine—muscle cancer	0.00164	0.00164	CcSEcCtD
Valganciclovir—Eosinophilia—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Valganciclovir—Paraesthesia—Etoposide—muscle cancer	0.00162	0.00162	CcSEcCtD
Valganciclovir—Haematuria—Methotrexate—muscle cancer	0.00162	0.00162	CcSEcCtD
Valganciclovir—Pancreatitis—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Valganciclovir—Dyspnoea—Etoposide—muscle cancer	0.00161	0.00161	CcSEcCtD
Valganciclovir—Somnolence—Etoposide—muscle cancer	0.0016	0.0016	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Methotrexate—muscle cancer	0.0016	0.0016	CcSEcCtD
Valganciclovir—Asthenia—Vincristine—muscle cancer	0.0016	0.0016	CcSEcCtD
Valganciclovir—Vomiting—Dactinomycin—muscle cancer	0.00159	0.00159	CcSEcCtD
Valganciclovir—Bronchitis—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Valganciclovir—Decreased appetite—Etoposide—muscle cancer	0.00157	0.00157	CcSEcCtD
Valganciclovir—Pancytopenia—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Etoposide—muscle cancer	0.00156	0.00156	CcSEcCtD
Valganciclovir—Fatigue—Etoposide—muscle cancer	0.00156	0.00156	CcSEcCtD
Valganciclovir—Constipation—Etoposide—muscle cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Pain—Etoposide—muscle cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Dysuria—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Neutropenia—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Valganciclovir—Haemoglobin—Methotrexate—muscle cancer	0.00153	0.00153	CcSEcCtD
Valganciclovir—Diarrhoea—Vincristine—muscle cancer	0.00152	0.00152	CcSEcCtD
Valganciclovir—Hepatitis—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Valganciclovir—Haemorrhage—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Valganciclovir—Pollakiuria—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Valganciclovir—Pharyngitis—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Valganciclovir—Urinary tract disorder—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Valganciclovir—Urethral disorder—Methotrexate—muscle cancer	0.00149	0.00149	CcSEcCtD
Valganciclovir—Weight decreased—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Valganciclovir—Feeling abnormal—Etoposide—muscle cancer	0.00149	0.00149	CcSEcCtD
Valganciclovir—Hyperglycaemia—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Valganciclovir—Nausea—Dactinomycin—muscle cancer	0.00148	0.00148	CcSEcCtD
Valganciclovir—Pneumonia—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Etoposide—muscle cancer	0.00148	0.00148	CcSEcCtD
Valganciclovir—Dizziness—Vincristine—muscle cancer	0.00147	0.00147	CcSEcCtD
Valganciclovir—Infestation—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Valganciclovir—Infestation NOS—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Valganciclovir—Visual impairment—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Valganciclovir—Renal failure—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Valganciclovir—Urticaria—Etoposide—muscle cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Stomatitis—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Jaundice—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Abdominal pain—Etoposide—muscle cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Body temperature increased—Etoposide—muscle cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Urinary tract infection—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Valganciclovir—Eye disorder—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Tinnitus—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Vomiting—Vincristine—muscle cancer	0.00142	0.00142	CcSEcCtD
Valganciclovir—Cardiac disorder—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Valganciclovir—Dermatitis—Vincristine—muscle cancer	0.0014	0.0014	CcSEcCtD
Valganciclovir—Haematuria—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Valganciclovir—Headache—Vincristine—muscle cancer	0.0014	0.0014	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Valganciclovir—Angiopathy—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Valganciclovir—Sinusitis—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
Valganciclovir—Immune system disorder—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Valganciclovir—Mediastinal disorder—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Valganciclovir—Chills—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Valganciclovir—Alopecia—Methotrexate—muscle cancer	0.00134	0.00134	CcSEcCtD
Valganciclovir—Mental disorder—Methotrexate—muscle cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Hypersensitivity—Etoposide—muscle cancer	0.00133	0.00133	CcSEcCtD
Valganciclovir—Malnutrition—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Haemoglobin—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Nausea—Vincristine—muscle cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Hepatitis—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Haemorrhage—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Valganciclovir—Pharyngitis—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Valganciclovir—Urinary tract disorder—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Valganciclovir—Oedema peripheral—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Valganciclovir—Dysgeusia—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Valganciclovir—Asthenia—Etoposide—muscle cancer	0.00129	0.00129	CcSEcCtD
Valganciclovir—Connective tissue disorder—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Valganciclovir—Urethral disorder—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Valganciclovir—Back pain—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Pruritus—Etoposide—muscle cancer	0.00128	0.00128	CcSEcCtD
Valganciclovir—Visual impairment—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Valganciclovir—Vision blurred—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Valganciclovir—Diarrhoea—Etoposide—muscle cancer	0.00123	0.00123	CcSEcCtD
Valganciclovir—Eye disorder—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Valganciclovir—Ill-defined disorder—Methotrexate—muscle cancer	0.00123	0.00123	CcSEcCtD
Valganciclovir—Tinnitus—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Valganciclovir—Anaemia—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Valganciclovir—Cardiac disorder—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Valganciclovir—Angiopathy—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Valganciclovir—Malaise—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Dizziness—Etoposide—muscle cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Immune system disorder—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Vertigo—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Mediastinal disorder—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Leukopenia—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Valganciclovir—Chills—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Valganciclovir—Arrhythmia—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Valganciclovir—Alopecia—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Valganciclovir—Cough—Methotrexate—muscle cancer	0.00116	0.00116	CcSEcCtD
Valganciclovir—Mental disorder—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Convulsion—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Vomiting—Etoposide—muscle cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Malnutrition—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Valganciclovir—Dermatitis—Etoposide—muscle cancer	0.00114	0.00114	CcSEcCtD
Valganciclovir—Headache—Etoposide—muscle cancer	0.00113	0.00113	CcSEcCtD
Valganciclovir—Flatulence—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Valganciclovir—Arthralgia—Methotrexate—muscle cancer	0.00113	0.00113	CcSEcCtD
Valganciclovir—Tension—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Valganciclovir—Dysgeusia—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00112	0.00112	CcSEcCtD
Valganciclovir—Discomfort—Methotrexate—muscle cancer	0.00111	0.00111	CcSEcCtD
Valganciclovir—Nervousness—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Valganciclovir—Back pain—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Valganciclovir—Muscle spasms—Doxorubicin—muscle cancer	0.0011	0.0011	CcSEcCtD
Valganciclovir—Confusional state—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Valganciclovir—Anaphylactic shock—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Valganciclovir—Vision blurred—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Valganciclovir—Infection—Methotrexate—muscle cancer	0.00107	0.00107	CcSEcCtD
Valganciclovir—Nausea—Etoposide—muscle cancer	0.00107	0.00107	CcSEcCtD
Valganciclovir—Ill-defined disorder—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Nervous system disorder—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Anaemia—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Thrombocytopenia—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Valganciclovir—Agitation—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Valganciclovir—Skin disorder—Methotrexate—muscle cancer	0.00105	0.00105	CcSEcCtD
Valganciclovir—Hyperhidrosis—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Valganciclovir—Malaise—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Valganciclovir—Vertigo—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Valganciclovir—Anorexia—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Valganciclovir—Leukopenia—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Valganciclovir—Hypotension—Methotrexate—muscle cancer	0.00101	0.00101	CcSEcCtD
Valganciclovir—Cough—Doxorubicin—muscle cancer	0.001	0.001	CcSEcCtD
Valganciclovir—Convulsion—Doxorubicin—muscle cancer	0.000994	0.000994	CcSEcCtD
Valganciclovir—Hypertension—Doxorubicin—muscle cancer	0.00099	0.00099	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000985	0.000985	CcSEcCtD
Valganciclovir—Insomnia—Methotrexate—muscle cancer	0.000978	0.000978	CcSEcCtD
Valganciclovir—Arthralgia—Doxorubicin—muscle cancer	0.000976	0.000976	CcSEcCtD
Valganciclovir—Anxiety—Doxorubicin—muscle cancer	0.000973	0.000973	CcSEcCtD
Valganciclovir—Paraesthesia—Methotrexate—muscle cancer	0.00097	0.00097	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00097	0.00097	CcSEcCtD
Valganciclovir—Discomfort—Doxorubicin—muscle cancer	0.000965	0.000965	CcSEcCtD
Valganciclovir—Dyspnoea—Methotrexate—muscle cancer	0.000964	0.000964	CcSEcCtD
Valganciclovir—Somnolence—Methotrexate—muscle cancer	0.000961	0.000961	CcSEcCtD
Valganciclovir—Dry mouth—Doxorubicin—muscle cancer	0.000955	0.000955	CcSEcCtD
Valganciclovir—Dyspepsia—Methotrexate—muscle cancer	0.000951	0.000951	CcSEcCtD
Valganciclovir—Confusional state—Doxorubicin—muscle cancer	0.000944	0.000944	CcSEcCtD
Valganciclovir—Decreased appetite—Methotrexate—muscle cancer	0.00094	0.00094	CcSEcCtD
Valganciclovir—Oedema—Doxorubicin—muscle cancer	0.000936	0.000936	CcSEcCtD
Valganciclovir—Anaphylactic shock—Doxorubicin—muscle cancer	0.000936	0.000936	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000933	0.000933	CcSEcCtD
Valganciclovir—Fatigue—Methotrexate—muscle cancer	0.000932	0.000932	CcSEcCtD
Valganciclovir—Infection—Doxorubicin—muscle cancer	0.00093	0.00093	CcSEcCtD
Valganciclovir—Pain—Methotrexate—muscle cancer	0.000924	0.000924	CcSEcCtD
Valganciclovir—Nervous system disorder—Doxorubicin—muscle cancer	0.000918	0.000918	CcSEcCtD
Valganciclovir—Thrombocytopenia—Doxorubicin—muscle cancer	0.000916	0.000916	CcSEcCtD
Valganciclovir—Tachycardia—Doxorubicin—muscle cancer	0.000913	0.000913	CcSEcCtD
Valganciclovir—Skin disorder—Doxorubicin—muscle cancer	0.000909	0.000909	CcSEcCtD
Valganciclovir—Hyperhidrosis—Doxorubicin—muscle cancer	0.000905	0.000905	CcSEcCtD
Valganciclovir—Anorexia—Doxorubicin—muscle cancer	0.000892	0.000892	CcSEcCtD
Valganciclovir—Feeling abnormal—Methotrexate—muscle cancer	0.000891	0.000891	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methotrexate—muscle cancer	0.000884	0.000884	CcSEcCtD
Valganciclovir—Hypotension—Doxorubicin—muscle cancer	0.000874	0.000874	CcSEcCtD
Valganciclovir—Urticaria—Methotrexate—muscle cancer	0.000859	0.000859	CcSEcCtD
Valganciclovir—Body temperature increased—Methotrexate—muscle cancer	0.000854	0.000854	CcSEcCtD
Valganciclovir—Abdominal pain—Methotrexate—muscle cancer	0.000854	0.000854	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000853	0.000853	CcSEcCtD
Valganciclovir—Insomnia—Doxorubicin—muscle cancer	0.000846	0.000846	CcSEcCtD
Valganciclovir—Paraesthesia—Doxorubicin—muscle cancer	0.00084	0.00084	CcSEcCtD
Valganciclovir—Dyspnoea—Doxorubicin—muscle cancer	0.000834	0.000834	CcSEcCtD
Valganciclovir—Somnolence—Doxorubicin—muscle cancer	0.000832	0.000832	CcSEcCtD
Valganciclovir—Dyspepsia—Doxorubicin—muscle cancer	0.000824	0.000824	CcSEcCtD
Valganciclovir—Decreased appetite—Doxorubicin—muscle cancer	0.000814	0.000814	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000808	0.000808	CcSEcCtD
Valganciclovir—Fatigue—Doxorubicin—muscle cancer	0.000807	0.000807	CcSEcCtD
Valganciclovir—Pain—Doxorubicin—muscle cancer	0.0008	0.0008	CcSEcCtD
Valganciclovir—Constipation—Doxorubicin—muscle cancer	0.0008	0.0008	CcSEcCtD
Valganciclovir—Hypersensitivity—Methotrexate—muscle cancer	0.000796	0.000796	CcSEcCtD
Valganciclovir—Asthenia—Methotrexate—muscle cancer	0.000775	0.000775	CcSEcCtD
Valganciclovir—Feeling abnormal—Doxorubicin—muscle cancer	0.000771	0.000771	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000765	0.000765	CcSEcCtD
Valganciclovir—Pruritus—Methotrexate—muscle cancer	0.000765	0.000765	CcSEcCtD
Valganciclovir—Urticaria—Doxorubicin—muscle cancer	0.000743	0.000743	CcSEcCtD
Valganciclovir—Body temperature increased—Doxorubicin—muscle cancer	0.00074	0.00074	CcSEcCtD
Valganciclovir—Abdominal pain—Doxorubicin—muscle cancer	0.00074	0.00074	CcSEcCtD
Valganciclovir—Diarrhoea—Methotrexate—muscle cancer	0.000739	0.000739	CcSEcCtD
Valganciclovir—Dizziness—Methotrexate—muscle cancer	0.000715	0.000715	CcSEcCtD
Valganciclovir—Hypersensitivity—Doxorubicin—muscle cancer	0.00069	0.00069	CcSEcCtD
Valganciclovir—Vomiting—Methotrexate—muscle cancer	0.000687	0.000687	CcSEcCtD
Valganciclovir—Dermatitis—Methotrexate—muscle cancer	0.000681	0.000681	CcSEcCtD
Valganciclovir—Headache—Methotrexate—muscle cancer	0.000677	0.000677	CcSEcCtD
Valganciclovir—Asthenia—Doxorubicin—muscle cancer	0.000671	0.000671	CcSEcCtD
Valganciclovir—Pruritus—Doxorubicin—muscle cancer	0.000662	0.000662	CcSEcCtD
Valganciclovir—Nausea—Methotrexate—muscle cancer	0.000642	0.000642	CcSEcCtD
Valganciclovir—Diarrhoea—Doxorubicin—muscle cancer	0.00064	0.00064	CcSEcCtD
Valganciclovir—Dizziness—Doxorubicin—muscle cancer	0.000619	0.000619	CcSEcCtD
Valganciclovir—Vomiting—Doxorubicin—muscle cancer	0.000595	0.000595	CcSEcCtD
Valganciclovir—Dermatitis—Doxorubicin—muscle cancer	0.00059	0.00059	CcSEcCtD
Valganciclovir—Headache—Doxorubicin—muscle cancer	0.000586	0.000586	CcSEcCtD
Valganciclovir—Nausea—Doxorubicin—muscle cancer	0.000556	0.000556	CcSEcCtD
